AbbVie | ABBV - Net Income

Stock Price
212.52
Daily Change
0.93 0.44%
Monthly
-6.38%
Yearly
22.00%
Q2 Forecast
202.55

AbbVie reported $1.82B in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
AbbVie USD 1.82B 1.63B Dec/2025
Abbott USD 1.78B 132M Dec/2025
ALKERMES USD 49.34M 33.42M Dec/2025
Amgen USD 1.33B 1.88B Dec/2025
AstraZeneca USD 2.33B 207M Dec/2025
Biogen USD 466.5M 168.3M Sep/2025
BioMarin Pharmaceutical USD -46.57M 15.83M Dec/2025
Bristol-Myers Squibb USD 1.09B 1.11B Dec/2025
Coherus Biosciences USD -37.64M 2.11M Dec/2025
Eisai JPY 17.18B 7.02B Dec/2025
Eli Lilly USD 6.64B 1.05B Dec/2025
Gilead Sciences USD 2.18B 869M Dec/2025
GlaxoSmithKline GBP 636M 1.38B Dec/2025
Infinity Pharmaceuticals USD -9.96M 1.09M Jun/2023
J&J USD 5.12B 36M Dec/2025
Medtronic USD 1.14B 231M Dec/2025
Merck USD 2.96B 2.82B Dec/2025
Neurocrine Biosciences USD 209.5M 102M Sep/2025
Novartis USD 2.41B 1.52B Dec/2025
Pacira USD 1.64M 3.8M Dec/2025
Perrigo USD -1.42B 1.43B Dec/2025
Pfizer USD -1.65B 5.19B Dec/2025
Regeneron Pharmaceuticals USD 844.6M 615.4M Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Sanofi EUR -801M 3.6B Dec/2025
UCB EUR 1.08B 608M Dec/2025
Ultragenyx Pharmaceutical USD -129M 51.41M Dec/2025
United Therapeutics USD 364.3M 25.6M Dec/2025
Vertex Pharmaceuticals USD 1.19B 108.2M Dec/2025
Zoetis USD 603M 118M Dec/2025